Alerts

Stryker is conducting an urgent product correction of certain lots of the HeartSine Defibrillator. Stryker is now attempting to reach the small percentage of customers affected.

Bliss Baby is recalling all batches of ARTG 351147 - Flatus tube, single-use - Lufti Colic Reliever, due to insufficient evidence provided to the TGA to support its safe use.

Ritalin and Artige immediate-release tablets are now also in shortage, and a shortage of Ritalin LA capsules is anticipated.

We are aware of products being sold in Australia that claim to contain, or influence the levels of, nicotinamide adenine dinucleotide (NAD, NAD+, NADH) or nicotinamide mononucleotide (NMN) in the body.

Acne medication warnings further highlight potential risks of mood-related changes and sexual disorders.

Several vitamin and perinatal (including preconception) products are being recalled due to a lack of or excessive levels of potassium iodine.

Takeda Pharmaceuticals Australia has issued a product alert for Vyvanse capsules due to minor packaging errors. The medication is safe to use as prescribed.

Magnum XXL capsules pose a serious risk to your health and should not be taken.

Further examples of counterfeit Ozempic-labelled products have been detected and stopped at the Australian border.

Reynard Health Supplies is conducting a Critical Recall of the above products. A contamination problem has been identified with the products.

More prominent warnings are being added to the Product Information and Consumer Medicine Information for all oral and injectable (systemic) fluoroquinolones to strengthen existing warnings about serious side effects.

Possible risk of learning, communication and behaviour problems in children born to men taking this medicine.

Extra safety information is being added to all montelukast products to highlight the existing warnings about serious behaviour and mood-related changes

Boston Scientific have advised that subsets of ACCOLADE and VISIONIST pacemakers have an increased risk of permanently entering Safety Mode which has limited functionality.

The supply of Ozempic (semaglutide) will continue to be limited until 31 December 2025

Pharmacists can use a Serious Scarcity Substitution Instrument (SSSI) to dispense Protaphane Penfill human insulin in the place of a Protaphane InnoLet cartridge.

Caruso's Natural Health Pty Ltd is recalling certain batches of WEE LESS, BLOAT EZE and ASHWAGANDHA 7500 due to suspected tampering.

Gold Max Blue capsules pose a serious risk to your health and should not be taken.

Dynamint X tablets pose a serious risk to your health and should not be taken.

MAXMAN tablets pose a serious risk to your health and should not be taken.

There is a potential for insulin leakage with the Accu-Chek Spirit 3.15 ml cartridge system due to a manufacturing problem.

Insulet is advising they have received complaints of Omnipod DASH PDM/controller battery depletion as a result of the 3G network deactivation in the region.

Due to the concerns and difficulties caused by such shortages, we are giving patients and prescribers early notification so that they can plan ahead.

Pharmacists may dispense alternative brands or strengths without a new prescription.

The oral antihistamine promethazine hydrochloride, sold as Phenergan and other generic brands, should not be given to children under 6 years of age.